摘要:
It is considered that MMP-13 inhibitors contribute to the treatment or prevention against the diseases caused by or related to activity of MMP-13, especially osteoarthritis (OA). Therefore, the development of MMP-13 inhibitors has been desired.A compound represented by the general formula (I): wherein Z is 1,4-phenylene and the like; R1 is hydroxy and the like; R2 is hydrogen atom, optionally substituted lower alkyl, and the like; R12 is hydrogen atom; or R2 and R12 taken together with the adjacent carbon atom may form a ring; R3 is hydrogen atom, optionally substituted lower alkyl, and the like; R4 is halogen, lower alkyl, and the like; m is 0, 1, or 2; X is a bond, —C≡C—, and the like; Y is optionally substituted phenyl, optionally substituted naphthyl, and the like, its optically active substance, their pharmaceutically acceptable salt, or a solvate thereof.
摘要翻译:认为MMP-13抑制剂有助于治疗或预防由MMP-13,特别是骨关节炎(OA)的活动引起的或与其相关的疾病。 因此,期望MMP-13抑制剂的发展。 由通式(I)表示的化合物:其中Z是1,4-亚苯基等; R 1是羟基等; R 2是氢原子,任选取代的低级烷基等; R 12是氢原子; 或R 2和R 12与相邻碳原子一起可以形成环; R 3是氢原子,任选取代的低级烷基等; R 4是卤素,低级烷基等; m为0,1或2; X是键,-C≡C-等; Y是任选取代的苯基,任选取代的萘基等,其光学活性物质,其药学上可接受的盐或其溶剂化物。
摘要:
A compound represented by the general formula (I-A): wherein R1 is hydroxy and the like; R2 is optionally substituted lower alkyl and the like; R3 is hydrogen atom and the like; R4 is optionally substituted arylene and the like; R5 is a group represented by the formula: R6 is optionally substituted aryl and the like, its optically active substance, their pharmaceutically acceptable salt, or a solvate thereof; and a metalloproteinase inhibitor containing them.
摘要:
A compound represented by the general formula (I-A): wherein R1 is hydroxy and the like; R2 is optionally substituted lower alkyl and the like; R3 is hydrogen atom and the like; R4 is optionally substituted arylene and the like; R5 is a group represented by the formula: R6 is optionally substituted aryl and the like, its optically active substance, their pharmaceutically acceptable salt, or a solvate thereof; and a metalloproteinase inhibitor containing them.
摘要翻译:由通式(I-A)表示的化合物:其中R 1是羟基等; R 2是任选取代的低级烷基等; R 3是氢原子等; R 4是任选取代的亚芳基等; R 5是由下式表示的基团:R 6是任选取代的芳基等,其光学活性物质,其药学上可接受的盐或其溶剂化物; 和含有它们的金属蛋白酶抑制剂。
摘要:
A compound of the formula (I): wherein R1 is hydroxy and the like; R2 is optionally substituted lower alkyl and the like; R3 is hydrogen atom and the like; R4 is optionally substituted arylene and the like; R5 is —C≡C— and the like; R6 is optionally substituted naphtyl and the like its optically active substance, its prodrug, their pharmaceutically acceptable salt, or solvate thereof.
摘要翻译:式(I)的化合物:其中R 1是羟基等; R 2是任选取代的低级烷基等; R 3是氢原子等; R 4是任选取代的亚芳基等; R 5是-C≡C-等; R 6是任选取代的萘基等,其光学活性物质,其前药,其药学上可接受的盐或溶剂化物。
摘要:
Sulfonamide derivatives having a matrix metalloprotease inhibiting effect, which are compounds represented by general formula (I), optical isomers of the same, pharmaceutically acceptable salts of both, or solvates of them: wherein R1 and R2 are each independently hydrogen atom, optionally substituted lower alkyl or the like; R3 is optionally substituted aryl, optionally substituted heteroaryl or the like; X is —CH═CH—, —O—, or —S—; Y is NHOH, hydroxy, or lower alkyloxy.
摘要:
A compound of the formula (I): wherein R1 is hydroxy and the like; R2 is optionally substituted lower alkyl and the like; R3 is hydrogen atom and the like; R4 is optionally substituted arylene and the like; R5 is a group represented by the formula: and the like; R6 is optionally substituted aryl and the like, its optically active substance, its prodrug, their pharmaceutically acceptable salt, or solvate thereof and metalloproteinase inhibitors containing them.
摘要翻译:式(I)的化合物:其中R 1是羟基等; R 2是任选取代的低级烷基等; R 3是氢原子等; R 4是任选取代的亚芳基等; R 5是由下式表示的基团:等等; R 6是任选取代的芳基等,其光学活性物质,其前药,其药学上可接受的盐或溶剂合物和含有它们的金属蛋白酶抑制剂。
摘要:
A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): wherein, for example, R1 and R2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R3 is 1,4-phenylene and 2,5-thiophendiyl; R4 is the substituents represented by the formula, etc.: wherein R5 is hydrogen atom, optionally substituted amino, etc.; and Y is NHOH or OH, its optically active substance, their pharmaceutically acceptable salt, or hydrate thereof.
摘要翻译:一种用于治疗或预防肾小球病的组合物,其含有式(I)化合物:其中,例如R 1和R 2各自独立地为氢原子,任选取代的低级烷基,任选取代的芳烷基等; R 3是1,4-亚苯基和2,5-噻吩二基; R 4是由式等表示的取代基:其中R 5是氢原子,任选取代的氨基等; 和Y是NHOH或OH,其光学活性物质,其药学上可接受的盐或水合物。
摘要:
A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): wherein, for example, R1 and R2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R3 is 1,4-phenylene and 2,5-thiophendiyl; R4 is the substituents represented by the formula, etc.: wherein R6 is hydrogen atom, optionally substituted amino, etc.; and Y is NHOH or OH, its optically active substance, their pharmaceutically acceptable salt, or hydrate thereof.
摘要:
A novel compound which is useful as an agent for treating and/or preventing emesis, vomiting and/or constipation.A compound represented by the formula (I): wherein R1 and R2 are each independently hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted aryl etc., R3 is hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkynyl, optionally substituted lower alkoxy etc., R4 is hydrogen or lower alkyl, R5 is hydrogen, lower alkyl, cycloalkyl lower alkyl or lower alkenyl, or a pharmaceutically acceptably salt, or a solvate thereof is provided.
摘要:
Provided is a detergent composition having components (A) and (B1): (A) a phosphate monoester (1), and (B1) a phosphate monoester (2), wherein n=1; components (A), (B1) and (B2): (A) a phosphate monoester (1), (B1) a phosphate monoester (2), wherein n=1, and (B2) a phosphate monoester (2), wherein n=2; components (A), (B1) and (B2): (A) a phosphate monoester (1), (B1) a phosphate monoester (2) wherein n=1, and (B2) a phosphate monoester (2), wherein n=2; components (A) and (C): (A) a phosphate monoester (1), and (C) a phosphate monoester (3); or a phosphate-based surfactant produced by reacting a compound obtained by adding to an alcohol an alkylene oxide of 2 to 4 carbon atoms, with phosphoric acid, a polyphosphoric acid or P2O5: The detergent composition is mild to the skin, is high in versatility, and has a good foaming property in weak acidic water or in hard water.
摘要翻译:本发明提供一种具有成分(A)和(B 1)的洗涤剂组合物:(A)磷酸酯单酯(1)和(B 1/3)磷酸酯单酯(2 ),其中n = 1; 组分(A),(B 1/2)和(B 2):(A)磷酸酯单酯(1),(B 1 H 2) 磷酸酯单酯(2),其中n = 1,和(B 2 H 2)磷酸酯单酯(2),其中n = 2; 组分(A),(B 1/2)和(B 2):(A)磷酸酯单酯(1),(B 1 H 2) 其中n = 1的磷酸酯单酯(2)和磷酸酯单酯(2)的(B 2)2,其中n = 2; 组分(A)和(C):(A)磷酸酯单酯(1)和(C)磷酸酯单酯(3); 或通过将通过向醇中加入2至4个碳原子的烯化氧获得的化合物与磷酸,多磷酸或P 2 O 5 O 5反应而制备的磷酸盐基表面活性剂, 洗涤剂组合物对皮肤温和,通用性高,在弱酸性水或硬水中具有良好的起泡性。